NCT03620513View on ClinicalTrials.gov

Pretreatment to Reduce Pain and Discomfort During Fiberoptic Nasal Pharyngoscopy and Laryngoscopy

PHASE4CompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

September 1, 2018

Primary Completion Date

January 16, 2019

Study Completion Date

February 16, 2019

Conditions
Throat Disorder
Interventions
DRUG

Decongestant (oxymetazoline 0.05%)

As described in arm/group

DRUG

Anesthesia (Lidocaine 15%)

As described in arm/group

DRUG

Decongestants and Anesthesia (oxymetazoline and lidocaine)

As described in arm/group

DRUG

Normal saline

Spray of normal saline as premedication

Trial Locations (1)

32500

Lumbini Medical College, Tānsen

Sponsors
All Listed Sponsors
lead

Lumbini Medical College

OTHER

NCT03620513 - Pretreatment to Reduce Pain and Discomfort During Fiberoptic Nasal Pharyngoscopy and Laryngoscopy | Biotech Hunter | Biotech Hunter